In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy

In Vitro Studies to Define the Cell-Surface and Intracellular Targets of Polyarginine-Conjugated Sodium Borocaptate as a Potential Delivery Agent for Boron Neutron Capture Therapy

Boron neutron capture therapy (BNCT) requires pharmaceutical innovations and molecular-based evidence of effectiveness to become a standard cancer therapeutic in the future. Recently, in Japan, 4-borono-L-phenylalanine (BPA) was approved as a boron agent for BNCT against head and neck (H&N) canc...

Full description

Bibliographic Details
Main Authors: Atsushi Fujimura, Seiji Yasui, Kazuyo Igawa, Ai Ueda, Kaori Watanabe, Tadashi Hanafusa, Yasuaki Ichikawa, Sachiko Yoshihashi, Kazuki Tsuchida, Atsunori Kamiya, Shuichi Furuya
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cells
Subjects:
boron neutron capture therapy (BNCT)
BSH-polyR
CD44
translational machinery
bioinformatics
Online Access:https://www.mdpi.com/2073-4409/9/10/2149

Internet

https://www.mdpi.com/2073-4409/9/10/2149

Similar Items